Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

EPA's Ethylene Oxide Plan May Hinder Other Air Toxics Regs No Photo Available

Gautama Mehta

A new proposal from the U.S. Environmental Protection Agency to weaken emission standards for a medical sterilizer could have broader ... (more story)

Eye On ERISA: A Chat With King & Spalding's Darren Shuler No Photo Available

Kellie Mejdrich

Increased scrutiny of health plans and the high costs of care are fueling a litigation uptick that's coming not just from plan partici... (more story)

Legislative Update: Cannabis And Psychedelics Bill Roundup No Photo Available

Sam Reisman

Virginia lawmakers last week gave final approval to legislation that would tax and regulate the sale of adult-use cannabis, Georgia le... (more story)